Stay updated on Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Site-wide notice about funding and data currency has been added, indicating the NIH Clinical Center is open and where to find operating status updates. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:33:01.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now includes a glossary toggle and new headers 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' along with 'No FEAR Act Data'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T06:27:38.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. This represents a minor site-version update and does not alter the study details, eligibility criteria, or user interactions.
    Difference
    0.1%
    Check dated 2026-01-14T03:37:16.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Updated the study's Locations information: a new Locations section is added and lists Kentucky, Minnesota, Missouri, and Nebraska. The previously separate state location entries (Kentucky Locations, Minnesota Locations, Missouri Locations, Nebraska Locations) have been removed in the new revision (v3.3.3).
    Difference
    0.5%
    Check dated 2025-12-23T22:05:24.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.2.0 to v3.3.2; no substantive content changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:31:33.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Removed the notice about potential disruptions due to a lapse in government funding; the ClinicalTrials.gov page content and study details remain intact. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:22:44.000Z thumbnail image

Stay in the know with updates to Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.